Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RCPT

RECEPTOS, INC. (RCPT)

(MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RCPT
DateTimeSourceHeadlineSymbolCompany
15/07/201509:36Dow Jones NewsCelgene to Buy Receptos for $7.2 Billion--3rd UpdateNASDAQ:RCPT(MM)
15/07/201508:37Dow Jones NewsCelgene to Buy Receptos for About $7.2 Billion--2nd UpdateNASDAQ:RCPT(MM)
15/07/201508:18Dow Jones NewsCelgene to Buy Receptos for About $7.2 Billion--UpdateNASDAQ:RCPT(MM)
15/07/201507:50Dow Jones NewsCelgene to Buy Receptos for About $7.2 BillionNASDAQ:RCPT(MM)
15/07/201507:46Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Receptos, Inc. of Commencement of an Investigation Concerni...NASDAQ:RCPT(MM)
15/07/201507:28Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:RCPT(MM)
15/07/201507:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCPT(MM)
15/07/201506:58Business WireCelgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory DiseasesNASDAQ:RCPT(MM)
13/07/201523:55The Motley Fool5 Drugs That Investors May Be UndervaluingNASDAQ:RCPT(MM)
03/07/201502:11The Motley FoolWhy Shares in Receptos Soared 15% in JuneNASDAQ:RCPT(MM)
12/06/201508:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RCPT(MM)
12/06/201506:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RCPT(MM)
02/06/201523:06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:RCPT(MM)
02/06/201507:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCPT(MM)
15/05/201522:00GlobeNewswire Inc.Receptos Announces Oral Plenary Presentation of TOUCHSTONE Phase 2 Induction Data at Digestive Disease Week 2015NASDAQ:RCPT(MM)
14/05/201522:00GlobeNewswire Inc.Receptos to Present at UBS Global Healthcare ConferenceNASDAQ:RCPT(MM)
07/05/201522:00GlobeNewswire Inc.Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare ConferenceNASDAQ:RCPT(MM)
07/05/201506:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RCPT(MM)
07/05/201500:28Analyst Ratings NetworkReceptos PT Raised to $202.00 (RCPT)NASDAQ:RCPT(MM)
06/05/201506:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCPT(MM)
06/05/201506:01GlobeNewswire Inc.Receptos Provides Business Update and Reports First Quarter 2015 Financial ResultsNASDAQ:RCPT(MM)
29/04/201522:00GlobeNewswire Inc.Receptos to Hold First Quarter 2015 Results Conference CallNASDAQ:RCPT(MM)
20/04/201501:07The Motley Fool3 Biotech Stocks That Could Be Developing Billion Dollar DrugsNASDAQ:RCPT(MM)
18/04/201506:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RCPT(MM)
18/04/201506:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RCPT(MM)
16/04/201523:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCPT(MM)
16/04/201522:00GlobeNewswire Inc.Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Coliti...NASDAQ:RCPT(MM)
02/04/201508:25The Motley FoolWhy Receptos, Inc. Shares Soared Higher TodayNASDAQ:RCPT(MM)
01/04/201523:00GlobeNewswire Inc.Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple SclerosisNASDAQ:RCPT(MM)
09/03/201523:00GlobeNewswire Inc.Receptos to Present at Barclays Global Healthcare ConferenceNASDAQ:RCPT(MM)
 Showing the most relevant articles for your search:NASDAQ:RCPT